Top Markets
Coin of the day
Human Metabolome Technologies, Inc. Human Metabolome Technologies, Inc.

Human Metabolome Technologies, Inc.

6090
Κατάταξη σε μετοχές #29374
Human Metabolome Technologies, Inc. is a biotechnology company based in... Human Metabolome Technologies, Inc. is a biotechnology company based in Tsuruoka, Japan, established in 2003. It focuses on developing and providing metabolomics technologies and solutions for a range of applications, including drug discovery, disease diagnosis, and food production primarily within Japan. The company offers a comprehensive suite of metabolome analysis services, encompassing global profiling, targeted assays, flux analysis, and lipidomics. Additionally, it develops biomarkers, such as Phosphorylethanolamine, which is measured in blood plasma as a marker for major depressive disorder. HMT's solutions address diverse areas like cancer metabolism, infectious diseases, basic and clinical research, food and nutrition, and microbiome studies. The company also fosters collaborations, notably with the Institute for Advanced Biosciences and Keio University, to further advance metabolome analysis technology.
Τιμή μετοχής
$3.86
Κεφαλαιοποίηση
$21.49M
Αλλαγή (1 ημέρα)
-0.17%
Αλλαγή (1 έτος)
-25.27%
Χώρα
JP
Εμπόριο Human Metabolome Technologies, Inc. (6090)

Κατηγορία

Ιστορικό τιμής μετοχής για την Human Metabolome Technologies, Inc. (6090)
Υψηλότερη τιμή κλεισίματος: $3.90 στις 2026-08-01

Χαμηλότερη τιμή κλεισίματος: $38.92 στις 2013-12-01
Ιστορικό τιμής μετοχής της Human Metabolome Technologies, Inc. από 2013 έως 2026
Ετήσια απόδοση τιμής μετοχής
Έτος Απόδοση
2026 (TTM) 6.42%
2025 5.53%
2024 -8.60%
2023 -16.34%
2022 -3.84%
2021 -27.40%
2020 -0.20%
2019 -31.00%
2018 -39.33%
2017 33.64%
2016 94.29%
2015 -35.63%
2014 -72.82%
2013 0.00%
Τιμή μετοχής για παρόμοιες εταιρείες ή ανταγωνιστές
Εταιρεία Τιμή μετοχής Μεταβολή 1Έτ% Χώρα
$552.07 41.28%
US
$168.77 504.69%
US
$1.03K 57.19%
NL
$117.42 -19.34%
AU
$753.28 8.59%
CH